Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Fondazione Lanza

InstitutionResearch output, impact & collaborations

Fondazione Lanza is a research organisation in Padova, IT. OpenAlex records 1,001 works and 52,092 citations for it. 233 researchers list it as their most recent affiliation.

1,001
Works
52,092
Citations
233
Researchers
65
Avg h-index

How has Fondazione Lanza's publication output changed over time?

ScholarIQpublication output · 1976–2009

Output grew0% over the shown period — from 1 works in 1976 to 1 in 2009.

1
1
1
1
1976200420072009

What are the most-cited papers on Fondazione Lanza?

ScholarIQmost cited works
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
R. Charles Coombes, Emma Hall, Lorna J. Gibson, Robert Paridaens, Jacek Jassem, T. Delozier, Stephen E. Jones, Isabel Álvarez, Gianfilippo Bertelli, Olaf Ortmann, Alan S. Coates, Emilio Bajetta, David Dodwell, Robert E. Coleman, Lesley Fallowfield, E. Mickiewicz, Jørn Andersen, Per Eystein Lønning, Giorgio Cocconi, Alan L. Stewart, Nick Stuart, Claire Snowdon, M. Carpentieri, Giorgio Massimini, Judith M. Bliss
New England Journal of Medicine. 20041,768 CitationsOPEN ACCESS
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Robert Pirker, Jose R. Pereira, Aleksandra Szczęsna, Joachim von Pawel, Maciej Krzakowski, Rodryg Ramlau, Ihor Vynnychenko, Keunchil Park, Chih-Teng Yu, Valentyn Ganul, Jae-Kyung Roh, Emilio Bajetta, Kenneth J. O’Byrne, Filippo de Marinis, Wilfried Eberhardt, Thomas Goddemeier, Michael Emig, U. Gatzemeier
The Lancet. 20091,356 CitationsOPEN ACCESS
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Gianni Bonadonna, Ercole Brusamolino, Pinuccia Valagussa, Anna Rossi, Luisa Brugnatelli, Cristina Brambilla, Mario De Lena, Gabriele Tancini, Emilio Bajetta, R Musumeci, Umberto Veronesi
New England Journal of Medicine. 19761,334 Citations
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R. Charles Coombes, Lucy Kilburn, CF Snowdon, Robert Paridaens, RE Coleman, SE Jones, Jacek Jassem, CJH van de Velde, T. Delozier, Isabel Álvarez, Lucia Del Mastro, Olaf Ortmann, K. Diedrich, AS Coates, Emilio Bajetta, Holmberg Sb, David Dodwell, E. Mickiewicz, J. Andersen, Per Eystein Lønning, Giorgio Cocconi, John Forbes, M. Castiglione, N Stuart, A. Stewart, Lesley Fallowfield, Gianfilippo Bertelli, Emma Hall, Richard Bogle, M. Carpentieri, E Colajori, Milayna Subar, Elizabeth Ireland, Judith M. Bliss
The Lancet. 2007911 Citations

How much of the research on Fondazione Lanza is open access?

ScholarIQopen access share
50%OPEN ACCESS
Gold
0%
Green
25%
Hybrid
0%
Bronze
25%
Closed
50%

Related on ScholarIQ

Liver Disease Diagnosis and Treatment
Top Topic
Blood Pressure and Hypertension Studies
Top Topic
Cardiovascular Function and Risk Factors
Top Topic
Heart Failure Treatment and Management
Top Topic
Heart Rate Variability and Autonomic Control
Top Topic
Acute Lymphoblastic Leukemia research
Top Topic
470M+ articles · free account